You are here

Article Text

Article menu
Download PDFPDF
Letter
Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion
  1. Paul B Greenberg,
  2. Adam Martidis,
  3. Adam H Rogers,
  4. Jay S Duker,
  5. Elias Reichel
  1. New England Eye Center, Tufts University School of Medicine, Boston, MA, USA
  1. Correspondence to: Elias Reichel, MD, New England Eye Center, Tufts University School of Medicine, 750 Washington Street, Box 450, Boston, MA 02111, USA; ereichel{at}lifespan.org

https://doi.org/10.1136/bjo.86.2.247

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    No proved treatment exists for macular oedema secondary to central retinal vein occlusion (CRVO) despite the potential for significant visual loss in affected eyes. We report a patient with bilateral non-ischaemic CRVOs and macular oedema treated with intravitreal triamcinolone acetonide.

    An 80 year old woman presented with a 2 week history of acute visual loss in her left eye (LE). She had a 9 month history of poor vision in her right eye (RE). On examination, visual acuity was counting fingers RE and 20/400 LE. Intraocular pressures were 12 and 14 mm Hg, respectively. Anterior segment examination showed bilateral pseudophakia with no evidence of neovascularisation. Dilated fundus examination revealed bilateral CRVOs with macular oedema. Collateral disc vessels were present in the RE. Fluorescein angiography showed diffuse leakage and blockage from intraretinal haemorrhages in both eyes with no areas of non-perfusion (Fig 1). …

    View Full Text